Cerebral Aneurysm Clinical Trial
Official title:
Multi-center, Single-blind, Prospective Cohort Study of Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation
In the stage of registration study, our purpose is to find out the safety range of activated coagulation time level in cerebral aneurysm and arteriovenous malformations with hybrid operation.
This study is divided into anticoagulation program in cerebral aneurysm with hybrid operation and anticoagulation program in cerebral arteriovenous malformations with hybrid operation two parts, and each part divide into two stage, on the stage of registration study. This study is a multi-center, single-blind, prospective cohort study. Record the patient's intraoperative activated coagulation time Changes in detail, to observe the effect of activated coagulation time maintenance level on hemorrhage event rate of Intraoperative and postoperative 48 hours, purpose to find out the safety range of activated coagulation time level in cerebral aneurysm and arteriovenous malformations with hybrid operation. On the stage of randomized controlled study. This study is a multicenter, single-blind, prospective, randomized controlled study. Patients is divided into intraoperative standard dose group of Heparin Sodium and low dose group of Heparin Sodium randomly. To observe the effect of different anticoagulation regimens on activated coagulation time safety coverage rate during surgery, and finally develop a scientific and effective intraoperative anticoagulant therapy program. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04583163 -
Variability in Transcranial Doppler Technique in Neuro-Critical Care Patients
|
||
| Recruiting |
NCT03306836 -
Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2
|
N/A | |
| Recruiting |
NCT02345395 -
Safety Study of Minimally Invasive Approaches to Unruptured Anterior Circulation Aneurysms
|
N/A | |
| Completed |
NCT00962546 -
Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage
|
N/A | |
| Recruiting |
NCT04141020 -
Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms
|
Phase 2 | |
| Recruiting |
NCT01460563 -
Valproic Acid, Magnesium Sulphate, Rocuronium Requirement, Postoperative Analgesia
|
N/A | |
| Completed |
NCT02507999 -
Goal-directed Therapy in Endovascular Coiling of Cerebral Aneurysm Patients
|
N/A | |
| Recruiting |
NCT02162654 -
Remote Ischemic Preconditioning for Intracranial Aneurysm Treatment
|
N/A | |
| Completed |
NCT01943591 -
DELTA Trial: Does Embolization With Larger Coils Lead to Better Treatment of Aneurysms Trial
|
N/A | |
| Recruiting |
NCT03815149 -
Safety and Clinical Effectiveness of Pipeline™ Shield Devices for Intracranial Aneurysms
|
||
| Completed |
NCT03152201 -
New Findings About Somatosensory Evoked Potentials (SEP) During Surgery for Cerebral Aneurysms
|
||
| Recruiting |
NCT02444832 -
Multicenter Retrospective Registry of Anterior Communicating Artery Aneurysms With Endovascular Therapy
|
N/A | |
| Active, not recruiting |
NCT05774782 -
Parent Artery Reconstruction for Cerebral Aneurysms Using a Novel Flow Diverter With Surface Modification
|
N/A | |
| Withdrawn |
NCT01878136 -
Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage
|
Phase 1/Phase 2 | |
| Completed |
NCT02455440 -
Esmolol Infusion in Patients Undergoing Craniotomy
|
Phase 3 | |
| Withdrawn |
NCT02011321 -
Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH)
|
Phase 2 | |
| Completed |
NCT00614887 -
Hypothalamo-, Pituitary-, Adrenal Axis Dysfunction in Subarachnoid Hemorrhage
|
||
| Terminated |
NCT02281721 -
Surpass Flow Diverter for Intracranial Aneurysms: SURMOUNT Registry Data Collection
|
||
| Completed |
NCT04963933 -
A Medical Device to Treat Brain Aneurysms
|
N/A | |
| Completed |
NCT02700607 -
Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity
|
N/A |